🇺🇸 FDA

Intelligence · Clinical Pipeline

Takeda Pipeline

All ClinicalTrials.gov programs at Takeda — phase, modality, and trial IDs.

Programs
1,179

Quick answer

Takeda has 1,179 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. MT203 80 mg or matching Placebo

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  2. MVC-101

    Takeda

    Solid Tumour

    phase 1 mab terminated

    1 trial

  3. Maribavir

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  4. Maribavir (400 mg)

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  5. Maribavir Commercial Tablet Formulation

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  6. Mesalamine

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  7. Metronidazole + MMX Mesalazine/mesalamine placebo

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  8. Mezagitamab

    Takeda

    Kidney Disease

    phase 1 small molecule completed

    2 trials

  9. Midazolam

    Takeda

    Carcinoma, Advanced ALK+ or ROS1+Non-Small-Cell Lung, Neoplasm, Advanced ALK+ or ROS1+Solid Tumors

    phase 1 small molecule completed

    1 trial

  10. Midazolam

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. Midazolam

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  12. Midazolam

    Takeda

    Carcinoma, Non-Small-Cell Lung

    phase 1 small molecule completed

    1 trial

  13. Mobocertinib

    Takeda

    Non-Small Cell Lung Cancer

    phase 1 small molecule active

    1 trial

  14. Mobocertinib

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  15. Mobocertinib

    Takeda

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  16. Mobocertinib

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  17. Niraparib

    Takeda

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  18. No Intervention

    Takeda

    Rheumatoid Arthritis

    phase 1 other completed

    1 trial

  19. NoV GI.1/GII.4 Bivalent VLP Vaccine

    Takeda

    Gastroenteritis

    phase 1 mab completed

    1 trial

  20. Ontamalimab

    Takeda

    Steatohepatitis

    phase 1 small molecule terminated

    1 trial

  21. Pembrolizumab

    Takeda

    Carcinoma, Non-Small-Cell Lung

    phase 1 small molecule completed

    1 trial

  22. Pevonedistat

    Takeda

    Advanced Solid Neoplasm

    phase 1 small molecule completed

    2 trials

  23. Pevonedistat

    Takeda

    Refractory Acute Lymphoblastic Leukemia

    phase 1 small molecule completed

    1 trial

  24. Pevonedistat

    Takeda

    Myelofibroses

    phase 1 small molecule terminated

    1 trial

  25. Pevonedistat

    Takeda

    Advanced Solid Tumors, Neoplasms, Advanced Solid

    phase 1 small molecule completed

    1 trial

  26. Pevonedistat

    Takeda

    Acute Myelogenous Leukemia

    phase 1 small molecule completed

    1 trial

  27. Pevonedistat 25 mg/m^2

    Takeda

    Leukemia, Myeloid, Acute

    phase 1 small molecule completed

    1 trial

  28. Pioglitazone

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  29. Placebo

    Takeda

    Virus, Zika

    phase 1 small molecule completed

    1 trial

  30. Ponatinib

    Takeda

    Chronic Myelogenous Leukemia

    phase 1 small molecule completed

    1 trial

  31. PvP001 100 mg

    Takeda

    Digestive System Disease

    phase 1 small molecule completed

    1 trial

  32. Radiolabeled Prucalopride Succinate

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  33. Radiolabeled SPD557

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  34. Radiolabeled SPD602 (FBS0701, SSP-004184)

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  35. Ramelteon 8 mg

    Takeda

    Insomnia

    phase 1 small molecule completed

    1 trial

  36. Recombinant ADAMTS13

    Takeda

    Hereditary Thrombotic Thrombocytopenic Purpura (TTP)

    phase 1 small molecule completed

    1 trial

  37. Recombinant human C1 esterase inhibitor

    Takeda

    Hereditary Angioedema (HAE)

    phase 1 small molecule completed

    1 trial

  38. Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII)

    Takeda

    Von Willebrand Disease

    phase 1 mab completed

    1 trial

  39. Roflumilast

    Takeda

    Schizophrenia

    phase 1 small molecule completed

    1 trial

  40. SHP465 12.5mg

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    phase 1 small molecule completed

    1 trial

  41. SHP639 (n=60)

    Takeda

    Primary Open-angle Glaucoma (POAG)

    phase 1 small molecule completed

    1 trial

  42. SHP643

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  43. SHP681

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  44. SPD422

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  45. SPD489 (Lisdexamfetamine dimesylate)

    Takeda

    Schizophrenia

    phase 1 small molecule completed

    1 trial

  46. SPD503

    Takeda

    Healthy

    phase 1 small molecule completed

    2 trials

  47. SPD544

    Takeda

    ADHD

    phase 1 small molecule completed

    1 trial

  48. SSP-002358

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Takeda have?

1,179 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.